HealthMontefiore Einstein Gets $10 Million Grant to Study Breast Cancer RelapseBy Naomi CalderNov 3, 2026, 8:06 PM UTC
HealthBioNTech Plans Pumitamig-Trodelvy Regimen in Breast Cancer TrialBy Naomi CalderOct 24, 2026, 1:47 AM UTC
HealthNovartis Reports 19.1% Lower Death Risk in Six-Year Kisqali AnalysisBy Naomi CalderOct 23, 2026, 10:08 PM UTC
HealthGaza’s Breast Cancer Diagnoses Trail Prewar Levels as Screening FaltersBy Naomi CalderOct 23, 2026, 5:16 AM UTC
HealthFDA Clears SimBioSys Breast Cancer Recurrence Risk SoftwareBy Naomi CalderOct 15, 2026, 4:02 PM UTC
